MindMed Starts Dosing Patients In Phase 1 Clinical Study On MDMA-Like Substances
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Tuesday that the first patient has been dosed
Read more
Mind Medicine
MindMed Sees Positive Results For Its LSD Treatment For Anxiety Disorders Published In Peer-Reviewed Journal
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday that the previously released positive topline data
Read more
Mindmed Completes 15-To-1 Reverse Split To Maintain Nasdaq Compliance
Mind Medicine (NEO: MMED) might be slightly more volatile over the next few sessions. The psychedelic firm late on Friday
Read more
Mind Medicine Begins Phase 2B Study On Treating Generalized Anxiety Disorder With LSD Variant
Mind Medicine (NEO: MMED) has officially seen patient trials under a Phase 2b study get underway as it looks to
Read more
MindMed Declares US$17.0 Million Net Loss, US$105.7 Million Cash Balance For Q2 2022
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday its financial results for Q2 2022. The
Read more
Mind Medicine Sees Co-Founder Become An Activist Shareholder Demanding Changes
An activist shareholder battle might be brewing at Mind Medicine (NEO: MMED). This morning, co-founder of the company Dr Scott
Read more
Mindmed To Conduct 15-To-1 Reverse Split To Meet Nasdaq Listing Requirements
In a classic Canadian small cap move, Mind Medicine (NEO: MMED) last night announced that it’s directors have approved a
Read more
Mind Medicine To Raise Up To $100 Million Via ATM Financing
Mind Medicine (NEO: MMED) last night announced that it will be conducting a financing. The company is looking to raise
Read more
MindMed Presents Positive Data Studying LSD In Treating Anxiety Disorders
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced today that its top collaborators have released positive topline
Read more
MindMed Declares US$93.0 Million Net Loss, US$133.5 Million Cash Balance For 2021
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced this morning its financial results for 2021. The biotech
Read more